Brief: Bone Therapeutics Announces Conclusions From Interim Analysis Of Phase III PREOB Study

Biosenic SA

07/11/2018 07:50

Nov 7(Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * ANNOUNCED ON TUESDAY CONCLUSIONS FROM INTERIM ANALYSIS OF
PHASE
III PREOB STUDY IN HIP OSTEONECROSIS
    * DSMB RECOMMENDED THE DISCONTINUATION OF THE TRIAL
    * CO IS TAKING STEPS TO NOTIFY INVESTIGATORS THAT ENROLMENT
OF
PATIENTS IN THE TRIAL IS BEING STOPPED
    * CO WILL FOCUS ITS CELL THERAPY DEVELOPMENT ACTIVITIES AND
RESOURCES ON ITS OFF-THE-SHELF, ALLOGENEIC PLATFORM, ALLOB

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNEjsk9K
    
 Further company coverage:  BOTHE.BR  
   


 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))